Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-361.21M
↓ 41% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-256.27M
Historical baseline
PeriodValueYoY Change
TTM$-361.21M-2.7%
2024$-351.67M+17.7%
2023$-427.43M-13.2%
2022$-377.74M-14.9%
2021$-328.72M-26.0%
2020$-260.80M-37.7%
2019$-189.43M-54.5%
2018$-122.62M-34.6%
2017$-91.11M-75.5%
2016$-51.92M-